CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 146 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.54 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,409,000 | -39.0% | 474,400 | -5.1% | 0.01% | -40.0% |
| Q2 2020 | $2,310,000 | -43.4% | 500,000 | -52.9% | 0.01% | -60.0% |
| Q1 2020 | $4,084,000 | -18.8% | 1,060,714 | -21.0% | 0.02% | -7.4% |
| Q4 2019 | $5,032,000 | -29.4% | 1,341,902 | 0.0% | 0.03% | -43.8% |
| Q3 2019 | $7,125,000 | -27.5% | 1,341,902 | -47.6% | 0.05% | -28.4% |
| Q2 2019 | $9,828,000 | -33.5% | 2,559,461 | -11.7% | 0.07% | -29.5% |
| Q1 2019 | $14,790,000 | +165.6% | 2,900,000 | 0.0% | 0.10% | +106.5% |
| Q4 2018 | $5,568,000 | -49.2% | 2,900,000 | 0.0% | 0.05% | -36.1% |
| Q3 2018 | $10,962,000 | -3.0% | 2,900,000 | -19.9% | 0.07% | -15.3% |
| Q2 2018 | $11,301,000 | +7.9% | 3,621,962 | -17.3% | 0.08% | -4.5% |
| Q1 2018 | $10,471,000 | -54.2% | 4,381,072 | -25.1% | 0.09% | -55.1% |
| Q4 2017 | $22,882,000 | +78.0% | 5,852,153 | +14.7% | 0.20% | +90.4% |
| Q3 2017 | $12,857,000 | -8.7% | 5,102,153 | 0.0% | 0.10% | -15.4% |
| Q2 2017 | $14,082,000 | +41.5% | 5,102,153 | 0.0% | 0.12% | +51.9% |
| Q1 2017 | $9,949,000 | +85.7% | 5,102,153 | 0.0% | 0.08% | +52.8% |
| Q4 2016 | $5,357,000 | -3.7% | 5,102,153 | 0.0% | 0.05% | +6.0% |
| Q3 2016 | $5,561,000 | +52.9% | 5,102,153 | -0.4% | 0.05% | +31.6% |
| Q2 2016 | $3,637,000 | -43.5% | 5,122,153 | -6.8% | 0.04% | -44.1% |
| Q1 2016 | $6,433,000 | -68.3% | 5,498,459 | -33.6% | 0.07% | -59.5% |
| Q4 2015 | $20,275,000 | -7.9% | 8,275,630 | +12.8% | 0.17% | -17.2% |
| Q3 2015 | $22,007,000 | -27.4% | 7,335,692 | 0.0% | 0.20% | -23.7% |
| Q2 2015 | $30,296,000 | -7.5% | 7,335,692 | -3.0% | 0.27% | -2.2% |
| Q1 2015 | $32,758,000 | +64.2% | 7,565,462 | +12.7% | 0.27% | +33.3% |
| Q4 2014 | $19,945,000 | -10.5% | 6,715,462 | 0.0% | 0.20% | -27.4% |
| Q3 2014 | $22,295,000 | +296.4% | 6,715,462 | +202.1% | 0.28% | +307.2% |
| Q2 2014 | $5,624,000 | +336.6% | 2,223,053 | +290.1% | 0.07% | +331.2% |
| Q1 2014 | $1,288,000 | – | 569,853 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 148,281 | $2,458 | 7.14% |
| GABLES CAPITAL MANAGEMENT INC. | 409,080 | $6,782,546 | 4.74% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,355,099 | $171,687,541 | 3.83% |
| JW Asset Management, LLC | 563,392 | $9,341,039 | 3.58% |
| Quantedge Capital Pte Ltd | 324,700 | $5,383,526 | 2.10% |
| Paradiem, LLC | 236,628 | $3,923,292 | 1.22% |
| SummerHaven Investment Management, LLC | 100,592 | $1,667,815 | 0.97% |
| Capital Impact Advisors, LLC | 46,096 | $764,272 | 0.94% |
| Yorktown Management & Research Co Inc | 50,000 | $829,000 | 0.89% |
| Seaport Global Advisors, LLC | 15,598 | $258,615 | 0.82% |